miR‐31 exemplifies this by directly targeting SOX10, resulting in melanoma growth suppression through inhibition of the PI3K/AKT pathway111—a mechanism that parallels SOX10's known activation of this same pathway, creating a regulatory circuit. The gene discussed is AKT1; the disease is melanoma.